Phase I Study of the Combination of Carfilzomib and Panobinostat for Patients with Relapsed and Refractory Myeloma: A Multiple Myeloma Research Consortium (MMRC) Clinical Trial

被引：0
|
作者：
Kaufman, Jonathan L. [1 ]
Zimmerman, Todd [2 ]
Rosenbaum, Cara A. [3 ]
Nooka, Ajay K. [1 ]
Heffner, Leonard T. [1 ]
Harvey, R. Donald [1 ]
Gleason, Charise [4 ]
Lewis, Colleen [1 ]
Sharp, Cathy [1 ]
Barron, Kenisha W. [1 ]
Lonial, Sagar [1 ]
机构：
[1] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[2] Univ Chicago Med, Chicago, IL USA
[3] Univ Chicago, Chicago, IL 60637 USA
[4] Emory Univ, Atlanta, GA 30322 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] PHASE I STUDY OF THE COMBINATION OF CARFILZOMIB AND PANOBINOSTAT FOR PATIENTS WITH RELAPSED AND REFRACTORY MYELOMA: A MULTICENTER MMRC CLINICAL TRIAL
    Kaufman, J.
    Zimmerman, T.
    Jakubowiak, A.
    Rosenbaum, C.
    Lewis, C.
    Harvey, D.
    Nooka, A.
    Heffner, L.
    Lonial, Sagar
    [J]. HAEMATOLOGICA, 2013, 98 : 322 - 323
  • [2] Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I Study
    Jonathan L. Kaufman
    Roberto Mina
    Andrzej J. Jakubowiak
    Todd L. Zimmerman
    Jeffrey J. Wolf
    Colleen Lewis
    Charise Gleason
    Cathy Sharp
    Thomas Martin
    Leonard T. Heffner
    Ajay K. Nooka
    R. Donald Harvey
    Sagar Lonial
    [J]. Blood Cancer Journal, 9
  • [3] Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I Study
    Kaufman, Jonathan L.
    Mina, Roberto
    Jakubowiak, Andrzej J.
    Zimmermann, Todd L.
    Wolf, Jeffrey J.
    Lewis, Colleen
    Gleason, Charise
    Sharp, Cathy
    Martin, Thomas
    Heffner, Leonard T.
    Nooka, Ajay K.
    Harvey, R. Donald
    Lonial, Sagar
    [J]. BLOOD CANCER JOURNAL, 2019, 9 (1)
  • [4] Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma
    Berdeja, Jesus G.
    Hart, Lowell L.
    Mace, Joseph R.
    Arrowsmith, Edward R.
    Essell, James H.
    Owera, Rami S.
    Hainsworth, John D.
    Flinn, Ian W.
    [J]. HAEMATOLOGICA, 2015, 100 (05) : 670 - 676
  • [5] A phase I MMRC clinical trial testing the combination of bortezomib and tipifarnib in relapsed/refractory multiple myeloma
    Lonial, S.
    Francis, D.
    Karanes, C.
    Trudel, S.
    Dollard, A.
    Harvey, D.
    Kaufman, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] A Phase I MMRC Clinical Trial Testing the Combination of Bortezomib and Tipifarnib in Relapsed/Refractory Multiple Myeloma
    Lonial, Sagar
    Francis, Dixil
    Karanes, Chatchada
    Trudel, Suzanne
    Reece, Donna E.
    Krishnan, Amrita
    Buacharem, Marc
    Smith, Renee
    Zaman, Faraz
    Gul, Engin
    Dollard, Akari M.
    Harvey, Donald
    Kaufman, Jonathan
    [J]. BLOOD, 2008, 112 (11) : 1270 - 1270
  • [7] Phase I/Ib study of carfilzomib and panobinostat with or without dexamethasone in patients with relapsed/refractory multiple myeloma
    Manasanch, Elisabet E.
    Shah, Jatin J.
    Lee, Hans C.
    Weber, Donna M.
    Thomas, Sheeba K.
    Amini, Behrang
    Olsem, Jasper
    Crumpton, Brandon
    Morphey, Ashley
    Berkova, Zuzana
    Feng, Lei
    Orlowski, Robert Z.
    [J]. HAEMATOLOGICA, 2020, 105 (05) : E242 - E245
  • [8] A phase I/II study of the combination of panobinostat (PAN) and carfilzomib (CFZ) in patients (pts) with relapsed or relapsed/refractory multiple myeloma (MM).
    Berdeja, Jesus G.
    Gregory, Tara K.
    Matous, Jeffrey
    Hart, Lowell L.
    Owera, Rami
    Mace, Joseph Ronald
    Essell, James H.
    Flinn, Ian
    Faber, Edward Anthony
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] A Phase I Study of Ixazomib in Combination with Panobinostat and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma
    Reu, Frederic J.
    Valent, Jason
    Malek, Ehsan
    Sobecks, Ronald M.
    Faiman, Beth M.
    Hamilton, Kimberly
    Elberson, Jamie
    Fada, Sherry
    Liu, Hien K.
    Samaras, Christy
    Smith, Mitchell R.
    [J]. BLOOD, 2015, 126 (23)
  • [10] A multicenter phase I trial of perifosine (KRX-0401) in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma: Preliminary results. Multiple myeloma research consortium (MMRC) trial
    Jakubowiak, A.
    Richardson, P.
    Zimmerman, T.
    Alsina, M.
    Lonial, S.
    Kendall, T.
    Hideshima, T.
    Sportelli, P.
    Birch, R.
    Henderson, I. C.
    Giusti, K.
    Anderson, K.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 154 - 155
12345